SCHEMBL1614778

SCHEMBL1614778

Cc1nn2c(=O)cc(-c3cc(F)c(Cl)nc3Cl)[nH]c2c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 4/20 0.46
KCNQ2 O43526 4/20 0.46
KCNQ1 P51787 1/20 0.46
TP53 P04637 3/20 0.38
MAPT P10636 5/20 0.36
KDM4E B2RXH2 4/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
PLAT P00750 3/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 2/20 0.34
HCRTR1 O43613 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CASP1 P29466 1/20 0.34
HSD17B10 Q99714 1/20 0.33
DCTPP1 Q9H773 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614776 0.92 PSD (0.39) KCNQ3KCNQ2KCNQ1MAPTKDM4E
SCHEMBL1613890 0.86 KCNQ3 (0.49) KCNQ3KCNQ2KCNQ1PLAT
SCHEMBL1613456 0.86 KCNQ3 (0.42) KCNQ3KCNQ2KCNQ1TP53MAPT
SCHEMBL1614789 0.86 MAPT (0.36) TP53MAPTKDM4ENPC1RAB9A
SCHEMBL10062354 0.86 KCNQ3 (0.54) KCNQ3KCNQ2KCNQ1KDM4EPLAT
SCHEMBL1615115 0.85 KCNQ3 (0.44) KCNQ3KCNQ2KCNQ1TP53MAPT
SCHEMBL1614481 0.84 KCNQ3 (0.52) KCNQ3KCNQ2TP53MAPTKDM4E
SCHEMBL1613674 0.84 KCNQ3 (0.40) KCNQ3KCNQ2KCNQ1MAPTKDM4E
SCHEMBL1614504 0.81 ADORA2A (0.45) TP53MAPTKDM4ENPC1RAB9A
SCHEMBL24221653 0.79 PLAT (0.43) TP53MAPTKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 KCNQ3 12/4885KCNQ2 9/4885KCNQ1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.